Dr. Siegel on Benefits With Transoral Surgery and Chemotherapy for Head and Neck Cancer
August 24th 2017Robert Siegel, MD, chair, professor of medicine, director, Division of Hematology/Oncology, George Washington University, discusses the benefits of chemotherapy and transoral surgery for patients with head and neck cancer.
Read More
Dr. Siegel on Study of Induction Chemotherapy and Transoral Surgery in Oropharyngeal Cancer
August 23rd 2017Robert Siegel, MD, chair, professor of medicine, director, Division of Hematology/Oncology, George Washington University, discusses a study of induction chemotherapy and transoral surgery in patients with oropharyngeal cancer.
Read More
Dr. Siegel on the Da Vinci Robotic Assisted Surgery Technique in Head and Neck Cancer
August 18th 2017Robert Siegel, MD, chair, professor of medicine, director, Division of Hematology/Oncology, George Washington University, discusses the da Vinci robotic-assisted surgery technique in head and neck cancer.
Read More
Dr. Siegel on Results of Chemotherapy and Transoral Surgery Study for Head and Neck Cancer
July 11th 2017Robert Siegel, MD, chair, professor of medicine, director, Division of Hematology/Oncology, George Washington University, discusses a phase II study investigating induction chemotherapy and transoral surgery for patients with head and neck cancer.
Read More
Dr. Siegel Discusses RT-Related AEs for Patients With Oropharyngeal Squamous Cell Carcinomas
July 6th 2017Robert Siegel, MD, chair, professor of medicine, director, Division of Hematology/Oncology, George Washington University, discusses the adverse events (AEs) associated with radiation therapy (RT) for patients with oropharyngeal squamous cell carcinomas.
Read More